GLENMARK PHARMACEUTICALS LIMITED
Ownership & governance
Executives 5Directors 9Avg age 62Avg tenure 7.2y
GS
Glenn Mario Saldanha
Chief Executive Officer
Age 56Since 1999-12-31Profile →
+13
Executives5
Board of directors9
CP
Cherylann Pinto→
Director/Board Member
Age 58—
GS
Glenn Mario Saldanha→
Chairman
Age 56Since 2011-05-11
BS
Blanche Elizabeth Saldanha→
Director/Board Member
Age 85Since 2009-08-13
SR
Sona Saira Ramasastry→
Director/Board Member
Age 50Since 2019-03-31
DB
Dipankar Bhattacharjee→
Director/Board Member
Age 61Since 2020-08-13
VI
Vijayalakshmi R. Iyer→
Director/Board Member
Age 71Since 2023-02-09
PS
Pradeep Kumar Sinha→
Director/Board Member
Age 71Since 2025-02-13
AM
Anurag Mantri→
Director/Board Member
Age 54Since 2025-05-26
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Saldanha Family | 45.44 % | 128,241,936 |
| HDFC Asset Management Co. Ltd. (Invt Mgmt) | 6.144 % | 17,338,002 |
| Norges Bank Investment Management | 3.491 % | 9,852,580 |
| Amansa Holdings Pvt Ltd. | 2.215 % | 6,251,753 |
| Invesco Asset Management (India) Pvt Ltd. | 2.129 % | 6,007,592 |
Catalog · 2026-07-09
Registry officers14
| Name | Role | Since | Shares |
|---|---|---|---|
| Anurag Mantri | Director of Finance/CFO | 2025-05-26 | - |
| Glenn Mario Saldanha | Chief Executive Officer | 1999-12-31 | - |
| Glenn Mario Saldanha | Chairman | 2011-05-11 | - |
| Anurag Mantri | Director/Board Member | 2025-05-26 | - |
| Blanche Elizabeth Saldanha | Director/Board Member | 2009-08-13 | - |
| Cherylann Pinto | Director/Board Member | — | - |
| Dipankar Bhattacharjee | Director/Board Member | 2020-08-13 | - |
| Patricia Andrews | Director/Board Member | 2025-08-13 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| Glenmark Holding SA | — |
| Glenmark Holding SA | — |
| Glenmark Pharmaceuticals Inc., USA | Pharmaceuticals: Major |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 2,512.82Range 2,100–2,750Analysts 11
2,100Mean 2,512.822,750
- Strong buy 3
- Buy 7
- Hold 2
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.